1 Market Overview
1.1 Product Overview and Scope of Therapeutic Apheresis Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Therapeutic Apheresis Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trolley Type
1.3.3 Desktop Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Therapeutic Apheresis Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.4.5 Experimental Study
1.4.6 Other
1.5 Global Therapeutic Apheresis Devices Market Size & Forecast
1.5.1 Global Therapeutic Apheresis Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Therapeutic Apheresis Devices Sales Quantity (2018-2029)
1.5.3 Global Therapeutic Apheresis Devices Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Asahi Kasei Medical
2.1.1 Asahi Kasei Medical Details
2.1.2 Asahi Kasei Medical Major Business
2.1.3 Asahi Kasei Medical Therapeutic Apheresis Devices Product and Services
2.1.4 Asahi Kasei Medical Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Asahi Kasei Medical Recent Developments/Updates
2.2 B.Braun
2.2.1 B.Braun Details
2.2.2 B.Braun Major Business
2.2.3 B.Braun Therapeutic Apheresis Devices Product and Services
2.2.4 B.Braun Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 B.Braun Recent Developments/Updates
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Therapeutic Apheresis Devices Product and Services
2.3.4 Fresenius Kabi Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fresenius Kabi Recent Developments/Updates
2.4 Nigale
2.4.1 Nigale Details
2.4.2 Nigale Major Business
2.4.3 Nigale Therapeutic Apheresis Devices Product and Services
2.4.4 Nigale Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Nigale Recent Developments/Updates
2.5 Miltenyi Biotec
2.5.1 Miltenyi Biotec Details
2.5.2 Miltenyi Biotec Major Business
2.5.3 Miltenyi Biotec Therapeutic Apheresis Devices Product and Services
2.5.4 Miltenyi Biotec Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Miltenyi Biotec Recent Developments/Updates
2.6 Terumo
2.6.1 Terumo Details
2.6.2 Terumo Major Business
2.6.3 Terumo Therapeutic Apheresis Devices Product and Services
2.6.4 Terumo Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Terumo Recent Developments/Updates
2.7 Lmb Technologie
2.7.1 Lmb Technologie Details
2.7.2 Lmb Technologie Major Business
2.7.3 Lmb Technologie Therapeutic Apheresis Devices Product and Services
2.7.4 Lmb Technologie Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lmb Technologie Recent Developments/Updates
2.8 JMS Singapore
2.8.1 JMS Singapore Details
2.8.2 JMS Singapore Major Business
2.8.3 JMS Singapore Therapeutic Apheresis Devices Product and Services
2.8.4 JMS Singapore Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 JMS Singapore Recent Developments/Updates
2.9 Sichuan Lantaina Detai Biotechnology
2.9.1 Sichuan Lantaina Detai Biotechnology Details
2.9.2 Sichuan Lantaina Detai Biotechnology Major Business
2.9.3 Sichuan Lantaina Detai Biotechnology Therapeutic Apheresis Devices Product and Services
2.9.4 Sichuan Lantaina Detai Biotechnology Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sichuan Lantaina Detai Biotechnology Recent Developments/Updates
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Therapeutic Apheresis Devices Product and Services
2.10.4 Haemonetics Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Haemonetics Recent Developments/Updates
3 Competitive Environment: Therapeutic Apheresis Devices by Manufacturer
3.1 Global Therapeutic Apheresis Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Therapeutic Apheresis Devices Revenue by Manufacturer (2018-2023)
3.3 Global Therapeutic Apheresis Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Therapeutic Apheresis Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Therapeutic Apheresis Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Therapeutic Apheresis Devices Manufacturer Market Share in 2022
3.5 Therapeutic Apheresis Devices Market: Overall Company Footprint Analysis
3.5.1 Therapeutic Apheresis Devices Market: Region Footprint
3.5.2 Therapeutic Apheresis Devices Market: Company Product Type Footprint
3.5.3 Therapeutic Apheresis Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Therapeutic Apheresis Devices Market Size by Region
4.1.1 Global Therapeutic Apheresis Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Therapeutic Apheresis Devices Consumption Value by Region (2018-2029)
4.1.3 Global Therapeutic Apheresis Devices Average Price by Region (2018-2029)
4.2 North America Therapeutic Apheresis Devices Consumption Value (2018-2029)
4.3 Europe Therapeutic Apheresis Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Therapeutic Apheresis Devices Consumption Value (2018-2029)
4.5 South America Therapeutic Apheresis Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Therapeutic Apheresis Devices Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Therapeutic Apheresis Devices Sales Quantity by Type (2018-2029)
5.2 Global Therapeutic Apheresis Devices Consumption Value by Type (2018-2029)
5.3 Global Therapeutic Apheresis Devices Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Therapeutic Apheresis Devices Sales Quantity by Application (2018-2029)
6.2 Global Therapeutic Apheresis Devices Consumption Value by Application (2018-2029)
6.3 Global Therapeutic Apheresis Devices Average Price by Application (2018-2029)
7 North America
7.1 North America Therapeutic Apheresis Devices Sales Quantity by Type (2018-2029)
7.2 North America Therapeutic Apheresis Devices Sales Quantity by Application (2018-2029)
7.3 North America Therapeutic Apheresis Devices Market Size by Country
7.3.1 North America Therapeutic Apheresis Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Therapeutic Apheresis Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Therapeutic Apheresis Devices Sales Quantity by Type (2018-2029)
8.2 Europe Therapeutic Apheresis Devices Sales Quantity by Application (2018-2029)
8.3 Europe Therapeutic Apheresis Devices Market Size by Country
8.3.1 Europe Therapeutic Apheresis Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Therapeutic Apheresis Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Therapeutic Apheresis Devices Market Size by Region
9.3.1 Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Therapeutic Apheresis Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Therapeutic Apheresis Devices Sales Quantity by Type (2018-2029)
10.2 South America Therapeutic Apheresis Devices Sales Quantity by Application (2018-2029)
10.3 South America Therapeutic Apheresis Devices Market Size by Country
10.3.1 South America Therapeutic Apheresis Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Therapeutic Apheresis Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Therapeutic Apheresis Devices Market Size by Country
11.3.1 Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Therapeutic Apheresis Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Therapeutic Apheresis Devices Market Drivers
12.2 Therapeutic Apheresis Devices Market Restraints
12.3 Therapeutic Apheresis Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Therapeutic Apheresis Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Therapeutic Apheresis Devices
13.3 Therapeutic Apheresis Devices Production Process
13.4 Therapeutic Apheresis Devices Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Therapeutic Apheresis Devices Typical Distributors
14.3 Therapeutic Apheresis Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Therapeutic Apheresis Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Therapeutic Apheresis Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Asahi Kasei Medical Basic Information, Manufacturing Base and Competitors
Table 4. Asahi Kasei Medical Major Business
Table 5. Asahi Kasei Medical Therapeutic Apheresis Devices Product and Services
Table 6. Asahi Kasei Medical Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Asahi Kasei Medical Recent Developments/Updates
Table 8. B.Braun Basic Information, Manufacturing Base and Competitors
Table 9. B.Braun Major Business
Table 10. B.Braun Therapeutic Apheresis Devices Product and Services
Table 11. B.Braun Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. B.Braun Recent Developments/Updates
Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 14. Fresenius Kabi Major Business
Table 15. Fresenius Kabi Therapeutic Apheresis Devices Product and Services
Table 16. Fresenius Kabi Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Fresenius Kabi Recent Developments/Updates
Table 18. Nigale Basic Information, Manufacturing Base and Competitors
Table 19. Nigale Major Business
Table 20. Nigale Therapeutic Apheresis Devices Product and Services
Table 21. Nigale Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Nigale Recent Developments/Updates
Table 23. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 24. Miltenyi Biotec Major Business
Table 25. Miltenyi Biotec Therapeutic Apheresis Devices Product and Services
Table 26. Miltenyi Biotec Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Miltenyi Biotec Recent Developments/Updates
Table 28. Terumo Basic Information, Manufacturing Base and Competitors
Table 29. Terumo Major Business
Table 30. Terumo Therapeutic Apheresis Devices Product and Services
Table 31. Terumo Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Terumo Recent Developments/Updates
Table 33. Lmb Technologie Basic Information, Manufacturing Base and Competitors
Table 34. Lmb Technologie Major Business
Table 35. Lmb Technologie Therapeutic Apheresis Devices Product and Services
Table 36. Lmb Technologie Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lmb Technologie Recent Developments/Updates
Table 38. JMS Singapore Basic Information, Manufacturing Base and Competitors
Table 39. JMS Singapore Major Business
Table 40. JMS Singapore Therapeutic Apheresis Devices Product and Services
Table 41. JMS Singapore Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. JMS Singapore Recent Developments/Updates
Table 43. Sichuan Lantaina Detai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Sichuan Lantaina Detai Biotechnology Major Business
Table 45. Sichuan Lantaina Detai Biotechnology Therapeutic Apheresis Devices Product and Services
Table 46. Sichuan Lantaina Detai Biotechnology Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sichuan Lantaina Detai Biotechnology Recent Developments/Updates
Table 48. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 49. Haemonetics Major Business
Table 50. Haemonetics Therapeutic Apheresis Devices Product and Services
Table 51. Haemonetics Therapeutic Apheresis Devices Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Haemonetics Recent Developments/Updates
Table 53. Global Therapeutic Apheresis Devices Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 54. Global Therapeutic Apheresis Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Therapeutic Apheresis Devices Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Therapeutic Apheresis Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Therapeutic Apheresis Devices Production Site of Key Manufacturer
Table 58. Therapeutic Apheresis Devices Market: Company Product Type Footprint
Table 59. Therapeutic Apheresis Devices Market: Company Product Application Footprint
Table 60. Therapeutic Apheresis Devices New Market Entrants and Barriers to Market Entry
Table 61. Therapeutic Apheresis Devices Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Therapeutic Apheresis Devices Sales Quantity by Region (2018-2023) & (Units)
Table 63. Global Therapeutic Apheresis Devices Sales Quantity by Region (2024-2029) & (Units)
Table 64. Global Therapeutic Apheresis Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Therapeutic Apheresis Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Therapeutic Apheresis Devices Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Therapeutic Apheresis Devices Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Therapeutic Apheresis Devices Sales Quantity by Type (2018-2023) & (Units)
Table 69. Global Therapeutic Apheresis Devices Sales Quantity by Type (2024-2029) & (Units)
Table 70. Global Therapeutic Apheresis Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Therapeutic Apheresis Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Therapeutic Apheresis Devices Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Therapeutic Apheresis Devices Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Therapeutic Apheresis Devices Sales Quantity by Application (2018-2023) & (Units)
Table 75. Global Therapeutic Apheresis Devices Sales Quantity by Application (2024-2029) & (Units)
Table 76. Global Therapeutic Apheresis Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Therapeutic Apheresis Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Therapeutic Apheresis Devices Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Therapeutic Apheresis Devices Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Therapeutic Apheresis Devices Sales Quantity by Type (2018-2023) & (Units)
Table 81. North America Therapeutic Apheresis Devices Sales Quantity by Type (2024-2029) & (Units)
Table 82. North America Therapeutic Apheresis Devices Sales Quantity by Application (2018-2023) & (Units)
Table 83. North America Therapeutic Apheresis Devices Sales Quantity by Application (2024-2029) & (Units)
Table 84. North America Therapeutic Apheresis Devices Sales Quantity by Country (2018-2023) & (Units)
Table 85. North America Therapeutic Apheresis Devices Sales Quantity by Country (2024-2029) & (Units)
Table 86. North America Therapeutic Apheresis Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Therapeutic Apheresis Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Therapeutic Apheresis Devices Sales Quantity by Type (2018-2023) & (Units)
Table 89. Europe Therapeutic Apheresis Devices Sales Quantity by Type (2024-2029) & (Units)
Table 90. Europe Therapeutic Apheresis Devices Sales Quantity by Application (2018-2023) & (Units)
Table 91. Europe Therapeutic Apheresis Devices Sales Quantity by Application (2024-2029) & (Units)
Table 92. Europe Therapeutic Apheresis Devices Sales Quantity by Country (2018-2023) & (Units)
Table 93. Europe Therapeutic Apheresis Devices Sales Quantity by Country (2024-2029) & (Units)
Table 94. Europe Therapeutic Apheresis Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Therapeutic Apheresis Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Type (2018-2023) & (Units)
Table 97. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Type (2024-2029) & (Units)
Table 98. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Application (2018-2023) & (Units)
Table 99. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Application (2024-2029) & (Units)
Table 100. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Region (2018-2023) & (Units)
Table 101. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Region (2024-2029) & (Units)
Table 102. Asia-Pacific Therapeutic Apheresis Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Therapeutic Apheresis Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Therapeutic Apheresis Devices Sales Quantity by Type (2018-2023) & (Units)
Table 105. South America Therapeutic Apheresis Devices Sales Quantity by Type (2024-2029) & (Units)
Table 106. South America Therapeutic Apheresis Devices Sales Quantity by Application (2018-2023) & (Units)
Table 107. South America Therapeutic Apheresis Devices Sales Quantity by Application (2024-2029) & (Units)
Table 108. South America Therapeutic Apheresis Devices Sales Quantity by Country (2018-2023) & (Units)
Table 109. South America Therapeutic Apheresis Devices Sales Quantity by Country (2024-2029) & (Units)
Table 110. South America Therapeutic Apheresis Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Therapeutic Apheresis Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Type (2018-2023) & (Units)
Table 113. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Type (2024-2029) & (Units)
Table 114. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Application (2018-2023) & (Units)
Table 115. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Application (2024-2029) & (Units)
Table 116. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Region (2018-2023) & (Units)
Table 117. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Region (2024-2029) & (Units)
Table 118. Middle East & Africa Therapeutic Apheresis Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Therapeutic Apheresis Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Therapeutic Apheresis Devices Raw Material
Table 121. Key Manufacturers of Therapeutic Apheresis Devices Raw Materials
Table 122. Therapeutic Apheresis Devices Typical Distributors
Table 123. Therapeutic Apheresis Devices Typical Customers
List of Figures
Figure 1. Therapeutic Apheresis Devices Picture
Figure 2. Global Therapeutic Apheresis Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Therapeutic Apheresis Devices Consumption Value Market Share by Type in 2022
Figure 4. Trolley Type Examples
Figure 5. Desktop Type Examples
Figure 6. Global Therapeutic Apheresis Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Therapeutic Apheresis Devices Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Experimental Study Examples
Figure 12. Other Examples
Figure 13. Global Therapeutic Apheresis Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Therapeutic Apheresis Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Therapeutic Apheresis Devices Sales Quantity (2018-2029) & (Units)
Figure 16. Global Therapeutic Apheresis Devices Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Therapeutic Apheresis Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Therapeutic Apheresis Devices Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Therapeutic Apheresis Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Therapeutic Apheresis Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Therapeutic Apheresis Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Therapeutic Apheresis Devices Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Therapeutic Apheresis Devices Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Therapeutic Apheresis Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Therapeutic Apheresis Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Therapeutic Apheresis Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Therapeutic Apheresis Devices Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Therapeutic Apheresis Devices Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Therapeutic Apheresis Devices Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Therapeutic Apheresis Devices Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Therapeutic Apheresis Devices Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Therapeutic Apheresis Devices Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Therapeutic Apheresis Devices Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Therapeutic Apheresis Devices Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Therapeutic Apheresis Devices Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Therapeutic Apheresis Devices Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Therapeutic Apheresis Devices Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Therapeutic Apheresis Devices Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Therapeutic Apheresis Devices Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Therapeutic Apheresis Devices Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Therapeutic Apheresis Devices Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Therapeutic Apheresis Devices Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Therapeutic Apheresis Devices Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Therapeutic Apheresis Devices Consumption Value Market Share by Region (2018-2029)
Figure 55. China Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Therapeutic Apheresis Devices Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Therapeutic Apheresis Devices Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Therapeutic Apheresis Devices Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Therapeutic Apheresis Devices Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Therapeutic Apheresis Devices Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Therapeutic Apheresis Devices Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Therapeutic Apheresis Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Therapeutic Apheresis Devices Market Drivers
Figure 76. Therapeutic Apheresis Devices Market Restraints
Figure 77. Therapeutic Apheresis Devices Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Therapeutic Apheresis Devices in 2022
Figure 80. Manufacturing Process Analysis of Therapeutic Apheresis Devices
Figure 81. Therapeutic Apheresis Devices Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
※参考情報 治療用アフェレシス装置は、血液中の特定の成分を選択的に取り出すことによって、さまざまな疾患の治療を行う医療機器です。この技術は、患者の血液を体外に取り出し、そこで処理を行った後に清浄化された血液を再び患者に戻すという方法で機能します。アフェレシスという言葉は、ギリシャ語の「aphairesis(取り出す)」に由来しており、その根底には選択的な成分の除去あるいは取り出しという概念があります。 治療用アフェレシス装置の特徴の一つは、選択的に血液成分を処理することができる点です。一般的な血液透析装置とは異なり、アフェレシス装置は血液から特定の細胞やタンパク質、免疫グロブリンなどを分離・除去し、残りの成分を保持します。このため、疾患に応じた治療を施すことが可能となります。また、治療の実施は比較的短時間で完了する場合が多く、患者にとっての負担が少ないという利点もあります。 アフェレシス装置は、その機能に応じていくつかの異なる種類に分類されます。一般的な分類には、血漿交換(Plasmapheresis)、血小板アフェレシス、白血球アフェレシス、赤血球アフェレシスなどがあります。血漿交換は、主に自己免疫疾患や神経変性疾患の治療に用いられ、多くの免疫因子や有害物質を除去することで患者の症状を軽減します。血小板アフェレシスは、特定の血液疾患や癌の治療に使われることが多く、白血球アフェレシスは、白血病やリンパ腫の治療に有用です。赤血球アフェレシスは、貧血やサラセミアなどによる血球の異常を治療するために使用されます。 治療用アフェレシス装置の用途は多岐にわたります。主に、自己免疫疾患、血液疾患、感染症、肝疾患、腎疾患などの治療に用いられています。例えば、重度の全身性エリテマトーデス(SLE)やギラン・バレー症候群の患者に対しては、血漿交換が効果的です。また、特定の癌患者に対しては、白血球アフェレシスが行われ、がん細胞を特異的に除去することが試みられています。アフェレシス技術は、臓器移植の際にも使用され、ドナーの血液から特定の成分を取り出すことで、移植後の拒絶反応を軽減する助けになります。 関連技術としては、血液成分の分離や濃縮に関する技術が挙げられます。遠心分離器を使用して血液中の成分を物理的に分離する方法が一般的で、これにより異なる成分を効率的に抽出できます。また、膜技術や吸着剤を利用した特定成分の除去方法もあり、それぞれのアフェレシス機器がこれらの技術を組み合わせて使用しています。 アフェレシス技術は、今後もさらなる進化が期待されています。技術の進化により、より効率的かつ安全な処置が可能となり、治療対象となる病態も広がっていくと考えられます。また、個別化医療の観点からも、患者の状態に応じた最適な治療法を選択する上で、アフェレシス技術は重要な役割を果たすでしょう。 最後に、治療用アフェレシス装置の利用には、患者の状態や病歴をきちんと考慮することが重要です。アフェレシスが適応される病態についての理解を深め、適切な臨床評価を行った上で治療を進めることが、治療の成功につながります。したがって、アフェレシス技術の運用には、専門的な知識と技術が必要であり、医療チームが協力して患者に対して最善の治療を提供することが求められます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/